0000000000011561

AUTHOR

F. Vacirca

showing 7 related works from this author

Il carcinoma prostatico in Sicilia e Calabria. età, stadiazione e PSA alla diagnosi

2004

researchProduct

Osservational Study on Early Diagnosis of Prostate Carcinoma in Sicily and Calabria

2004

The diagnosis of prostate carcinoma has been monitored in Sicily and Calabria for one year. Material e Methods Twenty-seven urological centres of Sicily and Calabria joined the study. Detailed informations about age, familiarity, PSA, Gleason score and TNM stage at diagnosis were centralized between november 2001 and november 2002. Results 721 patients have been recruited. The median age was 73 years. More than 80% of the patients were older than 65 years. Median PSA was 14 ng/ml. The clinical stage at diagnosis was T1c in 33% of patients and 67% had an organ confined prostate cancer (T1-T2). Familiarity was detected in 8% of cases. Age and PSA at diagnosis in these patients were similar t…

Oncologymedicine.medical_specialtybusiness.industryInternal medicinemedicineGeneral MedicineProstate carcinomabusinessUrologia Journal
researchProduct

Environmental Risk Factors in Superficial Bladder Cancer

2004

As a preliminary approach to define the object of larger case-control studies, the distribution of potential risk factors coming from environmental pollution among patients affected by superficial bladder cancer (TCCB) has been analyzed. Material e Methods. The analysis included only patients affected by medium risk superficial TCCB. Forty Italian urological centres joined the study. Detailed information about age, sex, residency, employment, active and passive cigarette smoking, water resource, hair-dye use were centralized. All patients underwent TUR and early intravesical chemotherapy. The distribution of the above mentioned environmental factors was related to tumor characteristics suc…

PollutionPotential riskbusiness.industrymedia_common.quotation_subjectDistribution (economics)Water supplyEnvironmental pollutionGeneral MedicineEnvironmental riskEnvironmental healthSuperficial bladder cancerEnvironmental sciencebusinessmedia_commonUrologia Journal
researchProduct

CHEMIOPROFILASSI PRECOCE CON EPIRUBICINA AD ALTA DOSE NEL CARCINOMA VESCICALE SUPERFICIALE. STUDIO RANDOMIZZATO DEL GSTU

2006

researchProduct

Architectures and protocols for mobile computing applications: a reconfigurable approach

2004

This work deals with reconfigurable control functions and protocols for supporting mobile computing applications in heterogeneous wireless systems like cellular networks and WLANs. The control functions are implemented in a software module, named Reconfigurable Access module for MObile computiNg applications (RAMON), placed in mobile and/or base stations. RAMON operates on abstract models of the main communication functions of a wireless systems (e.g., transmission over the radio channel, coding end error recovery, capacity sharing and packet scheduling, handover, congestion control, etc.). RAMON algorithms are programmed with reference to the abstract models, independently of specific radi…

Computer Networks and Communicationsbusiness.industryComputer sciencemobile computingComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKSMobile computingReconfigurabilityreconfigurable systemsresource controllaw.inventionBluetoothNetwork congestionBase stationHandoverlawmobile computing; mobility management; reconfigurable systems; resource control; session controlCellular networkWirelessbusinessMobility managementmobility managementUMTS frequency bandssession controlComputer network
researchProduct

A RANDOMISED STUDY EVALUATING MAINTENANCE SCHEDULE IN EARLY ADJUVANT CHEMOTHERAPY FOR INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER

2008

ABSTRACT Introduction and Objective: Adjuvant intravesical chemotherapy or BCG immunotherapy after transurethral resection (TUR) is a standard treatment for non–muscle-invasive transitional cell cancer of the bladder (NMI TCCB) at intermediate risk. Although the clinical value of early intravesical adjuvant chemotherapy is well established, the optimal schedule regimen and the role of maintenance is still debated. Methods: Between May 2002 and August 2003, 577 patients, undergoing TUR for NMI TCCB, were recruited. All patients underwent TUR and early (within 6 hours) intravesical chemotherapy with epirubicin at the dose of 80 mg diluted in 60 ml of saline solution. When histology was availa…

Oncologymedicine.medical_specialtyScheduleBladder cancerAdjuvant chemotherapybusiness.industryUrologymedicine.diseasebladder cancer EARLY ADJUVANT CHEMOTHERAPYInternal medicinemedicineNon muscle invasivebusinessIntermediate riskEuropean Urology Supplements
researchProduct

Tossicità e mantenimento nella chemioprofilassi endovescicale precoce (entro 6 ore) dopo TUR di carcinoma vescicale superficiale.

2006

researchProduct